Histone Deacetylase Inhibitor [EPC]

Histone Deacetylase Inhibitor [EPC] was reported 3874 times

Drugs of the Histone Deacetylase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 MYCOSIS FUNGOIDES REFRACTORY 2 0.3333
1 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED RECURRENT 19 0.2836
2 RADIATION HEPATITIS 6 0.2222
3 CD34 CELL COUNT DECREASED 2 0.2000
4 DUCHENNE MUSCULAR DYSTROPHY 12 0.1290
5 OVARIAN EPITHELIAL CANCER STAGE III 2 0.1250
6 HUMAN ANTI-MOUSE ANTIBODY POSITIVE 2 0.1176
7 ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA RECURRENT 2 0.0769
8 MYCOSIS FUNGOIDES RECURRENT 2 0.0690
9 ANORECTAL INFECTION BACTERIAL 1 0.0667
10 RHINITIS ATROPHIC 2 0.0645
11 LEPTOTRICHIA INFECTION 2 0.0444
12 DIPHTHERIA 2 0.0426
13 VASCULAR ACCESS SITE THROMBOSIS 2 0.0400
14 ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA 2 0.0328
15 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED 19 0.0320
16 ACUTE MYELOID LEUKAEMIA REFRACTORY 5 0.0291
17 TYMPANIC MEMBRANE HYPERAEMIA 2 0.0282
18 MYCOSIS FUNGOIDES 22 0.0267
19 INFESTATION 6 0.0232
20 SERRATIA TEST POSITIVE 2 0.0206
21 NEUROBLASTOMA RECURRENT 4 0.0197
22 T-CELL LYMPHOMA 19 0.0166
23 STOMATOCOCCAL INFECTION 2 0.0161
24 PNEUMOCOCCAL BACTERAEMIA 2 0.0159
25 BRAIN STEM GLIOMA 2 0.0132
26 ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA 4 0.0127
27 SINUSITIS ASPERGILLUS 2 0.0127
28 THYMUS ENLARGEMENT 2 0.0125
29 HYPERCALCAEMIA OF MALIGNANCY 3 0.0110
30 VULVAL ULCERATION 3 0.0106
31 FIBRIN DEGRADATION PRODUCTS INCREASED 3 0.0101
32 PSEUDOMONAL SEPSIS 15 0.0086
33 JEJUNAL PERFORATION 2 0.0083
34 INCISION SITE DISCHARGE 2 0.0079
35 LYMPHOCYTIC LEUKAEMIA 3 0.0074
36 HYPERVISCOSITY SYNDROME 2 0.0069
37 LYMPH GLAND INFECTION 3 0.0067
38 ENTEROCOLITIS INFECTIOUS 6 0.0065
39 ABDOMINAL WALL WOUND 1 0.0065
40 TUMOUR COMPRESSION 2 0.0063
41 SKIN FIBROSIS 3 0.0062
42 PARAKERATOSIS 2 0.0062
43 CELLULITE 2 0.0061
44 HYPERMAGNESAEMIA 4 0.0061
45 INJECTION SITE THROMBOSIS 2 0.0061
46 VOCAL CORD DYSFUNCTION 3 0.0061
47 ANAPLASTIC ASTROCYTOMA 1 0.0061
48 HYPERCREATINAEMIA 2 0.0060
49 ANASTOMOTIC COMPLICATION 2 0.0058
50 NON-CARDIAC CHEST PAIN 18 0.0057
51 PLASMABLASTIC LYMPHOMA 2 0.0056
52 HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION 2 0.0056
53 ACUTE MONOCYTIC LEUKAEMIA 1 0.0055
54 MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE 2 0.0054
55 HYPOPHOSPHATAEMIA 40 0.0054
56 ACANTHOSIS NIGRICANS 1 0.0054
57 HEPATOSPLENIC T-CELL LYMPHOMA 2 0.0054
58 NEUROBLASTOMA 2 0.0052
59 EMBOLISM 43 0.0052
60 METAPNEUMOVIRUS INFECTION 4 0.0051
61 TRICHOSPORON INFECTION 2 0.0049
62 TUMOUR ASSOCIATED FEVER 2 0.0049
63 ADENOVIRAL HAEMORRHAGIC CYSTITIS 1 0.0048
64 TROPONIN I INCREASED 8 0.0048
65 HEPATOBILIARY DISEASE 3 0.0048
66 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 4 0.0047
67 PSEUDOMONAL BACTERAEMIA 4 0.0047
68 STUBBORNNESS 2 0.0046
69 MANTLE CELL LYMPHOMA RECURRENT 2 0.0046
70 STREPTOCOCCAL BACTERAEMIA 5 0.0046
71 CANDIDA SEPSIS 4 0.0045
72 FEBRILE NEUTROPENIA 292 0.0044
73 TORSADE DE POINTES 34 0.0043
74 VIRAL HAEMORRHAGIC CYSTITIS 3 0.0042
75 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 21 0.0041
76 EPSTEIN BARR VIRUS POSITIVE MUCOCUTANEOUS ULCER 2 0.0041
77 ACTIVATED PARTIAL THROMBOPLASTIN TIME ABNORMAL 1 0.0040
78 MYELOID LEUKAEMIA 2 0.0040
79 CUTANEOUS T-CELL LYMPHOMA 5 0.0040
80 ANORECTAL INFECTION 1 0.0040
81 URINARY TRACT PAIN 2 0.0040
82 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 9 0.0039
83 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 5 0.0038
84 SUPERINFECTION BACTERIAL 3 0.0038
85 LYMPHOPENIA 53 0.0037
86 AUTOSCOPY 2 0.0037
87 VASCULAR ACCESS COMPLICATION 3 0.0037
88 PNEUMONIA STREPTOCOCCAL 4 0.0036
89 INTRACRANIAL HAEMATOMA 2 0.0036
90 OVARIAN CANCER METASTATIC 3 0.0035
91 BLOOD TRIGLYCERIDES INCREASED 62 0.0035
92 STAPHYLOCOCCAL BACTERAEMIA 15 0.0034
93 PAROTITIS 4 0.0034
94 ESCHERICHIA BACTERAEMIA 8 0.0034
95 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 2 0.0034
96 OROPHARYNGEAL CANDIDIASIS 3 0.0033
97 SOFT TISSUE INFECTION 6 0.0033
98 KLEBSIELLA BACTERAEMIA 3 0.0032
99 TELANGIECTASIA 3 0.0031
100 ACUTE MYELOID LEUKAEMIA 48 0.0031
101 LYMPHOCELE 2 0.0030
102 MESENTERIC VEIN THROMBOSIS 3 0.0030
103 TUMOUR FLARE 2 0.0029
104 SOFT TISSUE NECROSIS 2 0.0029
105 ANASTOMOTIC LEAK 2 0.0029
106 ANION GAP DECREASED 1 0.0029
107 FUSARIUM INFECTION 2 0.0029
108 STEM CELL TRANSPLANT 7 0.0028
109 CARDIAC ENZYMES INCREASED 2 0.0028
110 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 6 0.0027
111 HEMIANOPIA HOMONYMOUS 2 0.0027
112 GASTROINTESTINAL TOXICITY 13 0.0027
113 ELECTROCARDIOGRAM QT PROLONGED 97 0.0027
114 ANISOCORIA 1 0.0026
115 PLATELET COUNT DECREASED 282 0.0026
116 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 16 0.0026
117 ALKALOSIS 1 0.0026
118 MALIGNANT ASCITES 2 0.0026
119 LOCALISED OEDEMA 12 0.0026
120 ADRENAL GLAND CANCER 1 0.0026
121 HYPOALBUMINAEMIA 20 0.0026
122 SYSTEMIC MYCOSIS 3 0.0026
123 FUNGAEMIA 4 0.0025
124 STREPTOCOCCAL SEPSIS 3 0.0025
125 HAEMATOTOXICITY 24 0.0025
126 URETERIC STENOSIS 2 0.0025
127 HYPERURICAEMIA 10 0.0024
128 VASCULAR DEVICE INFECTION 11 0.0024
129 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 1 0.0024
130 ADRENAL SUPPRESSION 2 0.0024
131 MALIGNANT PLEURAL EFFUSION 4 0.0024
132 ACUTE MYELOID LEUKAEMIA RECURRENT 5 0.0023
133 HYPOCALCAEMIA 44 0.0023
134 EOSINOPHILIC PNEUMONIA ACUTE 2 0.0023
135 EMBOLISM VENOUS 7 0.0023
136 THROMBOCYTOPENIA 257 0.0023
137 ELECTROCARDIOGRAM ABNORMAL 18 0.0023
138 PNEUMONIA FUNGAL 9 0.0023
139 PERIPHERAL SENSORY NEUROPATHY 13 0.0022
140 PNEUMONIA KLEBSIELLA 4 0.0022
141 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 2 0.0022
142 ADRENAL NEOPLASM 1 0.0021
143 LUNG INFECTION 33 0.0021
144 CYTOPENIA 26 0.0021
145 ESCHERICHIA SEPSIS 6 0.0021
146 TUMOUR LYSIS SYNDROME 18 0.0020
147 SINUS TACHYCARDIA 29 0.0020
148 PSEUDOMONAS INFECTION 17 0.0020
149 NEUTROPENIC SEPSIS 14 0.0020
150 GRAFT VERSUS HOST DISEASE 14 0.0019
151 NEUTROPHIL COUNT DECREASED 79 0.0019
152 BRUGADA SYNDROME 2 0.0019
153 ACQUIRED IMMUNODEFICIENCY SYNDROME 1 0.0019
154 LYMPHOCYTE COUNT DECREASED 34 0.0019
155 MUCOSAL INFLAMMATION 50 0.0019
156 SYSTOLIC DYSFUNCTION 2 0.0019
157 NASAL INFLAMMATION 2 0.0019
158 TUMOUR NECROSIS 2 0.0019
159 COLON CANCER METASTATIC 3 0.0019
160 AORTIC VALVE DISEASE 3 0.0019
161 THERAPY PARTIAL RESPONDER 29 0.0019
162 ACIDOSIS 14 0.0018
163 ELECTROCARDIOGRAM T WAVE INVERSION 4 0.0018
164 PERIRECTAL ABSCESS 2 0.0018
165 HAEMOGLOBINURIA 2 0.0018
166 ACUTE PULMONARY OEDEMA 10 0.0018
167 FEMALE GENITAL TRACT FISTULA 3 0.0018
168 DEVICE RELATED INFECTION 27 0.0018
169 ACUTE PRERENAL FAILURE 2 0.0017
170 MYELODYSPLASTIC SYNDROME 25 0.0017
171 HYPERTRIGLYCERIDAEMIA 10 0.0017
172 TONGUE HAEMORRHAGE 2 0.0017
173 FEBRILE INFECTION 2 0.0017
174 LUNG INFILTRATION 15 0.0017
175 BONE MARROW TOXICITY 2 0.0017
176 FIBRIN D DIMER INCREASED 6 0.0017
177 DIFFUSE LARGE B-CELL LYMPHOMA 13 0.0017
178 INTRA-ABDOMINAL HAEMORRHAGE 4 0.0017
179 DISEASE PROGRESSION 197 0.0017
180 HEPATITIS B 10 0.0017
181 LEFT VENTRICULAR DYSFUNCTION 11 0.0016
182 BREATH ODOUR 4 0.0016
183 BACTERAEMIA 19 0.0016
184 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 12 0.0016
185 PERIPHERAL SENSORIMOTOR NEUROPATHY 2 0.0016
186 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 2 0.0016
187 HUMAN HERPESVIRUS 6 INFECTION 3 0.0016
188 HYPOMAGNESAEMIA 22 0.0016
189 MALLORY-WEISS SYNDROME 2 0.0016
190 POSTOPERATIVE WOUND COMPLICATION 2 0.0016
191 PNEUMONIA VIRAL 5 0.0016
192 ENTEROCOLITIS 9 0.0016
193 PLATELET TRANSFUSION 2 0.0016
194 HYPERBILIRUBINAEMIA 16 0.0015
195 FAILURE TO THRIVE 8 0.0015
196 CYTOMEGALOVIRUS CHORIORETINITIS 3 0.0015
197 HYPOKALAEMIA 71 0.0015
198 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 4 0.0015
199 TUMOUR PAIN 2 0.0015
200 GENE MUTATION 3 0.0015
201 CYSTITIS NONINFECTIVE 2 0.0015
202 SIALOADENITIS 2 0.0015
203 NEUTROPENIC COLITIS 3 0.0014
204 PLEURITIC PAIN 4 0.0014
205 SINUS BRADYCARDIA 14 0.0014
206 VIRAEMIA 2 0.0014
207 PULSELESS ELECTRICAL ACTIVITY 6 0.0014
208 PERIPHERAL MOTOR NEUROPATHY 2 0.0014
209 HYPERGLYCAEMIA 52 0.0014
210 THROMBOPHLEBITIS 5 0.0014
211 ACUTE LYMPHOCYTIC LEUKAEMIA 4 0.0014
212 FEBRILE BONE MARROW APLASIA 6 0.0014
213 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 3 0.0014
214 ANAEMIA MACROCYTIC 3 0.0014
215 HYPOXIA 49 0.0014
216 BLOOD LACTATE DEHYDROGENASE INCREASED 22 0.0014
217 ADENOVIRUS INFECTION 4 0.0014
218 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 7 0.0014
219 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 3 0.0014
220 SEPSIS 151 0.0014
221 AMPHETAMINES POSITIVE 1 0.0013
222 SMALL CELL LUNG CANCER 2 0.0013
223 CLOSTRIDIUM DIFFICILE COLITIS 14 0.0013
224 PARAINFLUENZAE VIRUS INFECTION 2 0.0013
225 PNEUMONIA PSEUDOMONAL 2 0.0013
226 HYPERCALCAEMIA 16 0.0013
227 RHINOVIRUS INFECTION 5 0.0013
228 HAEMORRHAGE INTRACRANIAL 19 0.0013
229 VARICELLA 3 0.0013
230 OPTIC NERVE DISORDER 2 0.0012
231 PNEUMONIA LEGIONELLA 2 0.0012
232 SMALL INTESTINAL OBSTRUCTION 15 0.0012
233 BRADYARRHYTHMIA 2 0.0012
234 EXTRAVASATION 5 0.0012
235 ELECTROLYTE IMBALANCE 14 0.0012
236 GASTROINTESTINAL TUBE INSERTION 3 0.0012
237 SYSTEMIC CANDIDA 3 0.0012
238 LEUKAEMIA RECURRENT 2 0.0012
239 BONE MARROW FAILURE 24 0.0012
240 PHLEBITIS 6 0.0012
241 HEPATOSPLENOMEGALY 3 0.0012
242 ANAEMIA 222 0.0012
243 SERUM FERRITIN DECREASED 2 0.0012
244 PULMONARY HAEMORRHAGE 9 0.0011
245 SUPRAVENTRICULAR TACHYCARDIA 11 0.0011
246 APLASTIC ANAEMIA 6 0.0011
247 EXTREMITY NECROSIS 2 0.0011
248 MELANOCYTIC NAEVUS 5 0.0011
249 NECROTISING FASCIITIS 4 0.0011
250 JUGULAR VEIN THROMBOSIS 2 0.0011
251 EPSTEIN-BARR VIRUS INFECTION 7 0.0011
252 PYODERMA GANGRENOSUM 4 0.0011
253 NEUTROPENIA 151 0.0011
254 OPHTHALMIC HERPES ZOSTER 2 0.0011
255 BLOOD HIV RNA INCREASED 2 0.0011
256 PNEUMONITIS 30 0.0011
257 HYDROCEPHALUS 6 0.0011
258 HYPONATRAEMIA 62 0.0011
259 OPPORTUNISTIC INFECTION 2 0.0011
260 INTERVERTEBRAL DISCITIS 2 0.0011
261 BONE MARROW TRANSPLANT 2 0.0011
262 CARDIAC TAMPONADE 5 0.0011
263 TUMOUR HAEMORRHAGE 3 0.0011
264 PNEUMONIA CYTOMEGALOVIRAL 2 0.0010
265 ADRENOCORTICAL INSUFFICIENCY ACUTE 2 0.0010
266 PNEUMONIA STAPHYLOCOCCAL 2 0.0010
267 CANDIDA INFECTION 17 0.0010
268 HYPERNATRAEMIA 5 0.0010
269 ATRIAL FLUTTER 8 0.0010
270 COLITIS 38 0.0010
271 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
272 BLOOD BILIRUBIN INCREASED 27 0.0010
273 CENTRAL VENOUS CATHETERISATION 3 0.0010
274 SMALL INTESTINAL HAEMORRHAGE 2 0.0010
275 DERMATITIS PSORIASIFORM 2 0.0010
276 BLOOD ALKALINE PHOSPHATASE INCREASED 24 0.0010
277 HEPATITIS B REACTIVATION 3 0.0009
278 ORTHOPNOEA 3 0.0009
279 CUSHINGOID 3 0.0009
280 BACTERIAL SEPSIS 3 0.0009
281 MALIGNANT NEOPLASM PROGRESSION 94 0.0009
282 DEHYDRATION 122 0.0009
283 ORAL CANDIDIASIS 12 0.0009
284 GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0009
285 PARESIS 2 0.0009
286 PNEUMOCYSTIS JIROVECI PNEUMONIA 2 0.0009
287 RESPIRATORY FAILURE 65 0.0009
288 LARGE INTESTINAL HAEMORRHAGE 2 0.0009
289 CLOSTRIDIAL INFECTION 3 0.0009
290 B-CELL LYMPHOMA 3 0.0009
291 BLOOD ALBUMIN DECREASED 7 0.0009
292 BRONCHOPNEUMONIA 3 0.0009
293 HERPES VIRUS INFECTION 5 0.0009
294 GRANULOMA 3 0.0009
295 AORTIC THROMBOSIS 1 0.0009
296 PETECHIAE 9 0.0009
297 PULMONARY TOXICITY 6 0.0008
298 TRANSPLANT 2 0.0008
299 PULSE ABSENT 4 0.0008
300 SUBCUTANEOUS ABSCESS 4 0.0008
301 RADIUS FRACTURE 2 0.0008
302 GASTROENTERITIS VIRAL 15 0.0008
303 ENTEROCOCCAL INFECTION 4 0.0008
304 PANNICULITIS 2 0.0008
305 BLOOD PHOSPHORUS DECREASED 3 0.0008
306 THROMBOCYTOSIS 3 0.0008
307 DERMATITIS EXFOLIATIVE 4 0.0008
308 VENOOCCLUSIVE DISEASE 2 0.0008
309 AORTIC VALVE REPLACEMENT 1 0.0008
310 PROTEIN TOTAL DECREASED 3 0.0008
311 KLEBSIELLA INFECTION 4 0.0008
312 DERMATOMYOSITIS 2 0.0008
313 EPISTAXIS 59 0.0008
314 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 3 0.0008
315 CARDIOTOXICITY 7 0.0008
316 CANCER PAIN 2 0.0008
317 GASTRIC HAEMORRHAGE 9 0.0008
318 CEREBRAL ISCHAEMIA 4 0.0008
319 SPINAL CORD COMPRESSION 3 0.0008
320 MUCORMYCOSIS 2 0.0008
321 PANCYTOPENIA 43 0.0008
322 ANAEMIA POSTOPERATIVE 1 0.0008
323 VENOUS THROMBOSIS 3 0.0008
324 SUDDEN DEATH 8 0.0008
325 MULTI-ORGAN FAILURE 13 0.0008
326 APPENDICITIS 7 0.0007
327 ALANINE AMINOTRANSFERASE INCREASED 46 0.0007
328 SPINAL FUSION SURGERY 3 0.0007
329 BEHAVIOUR DISORDER 4 0.0007
330 ASPARTATE AMINOTRANSFERASE INCREASED 39 0.0007
331 SKIN LESION 20 0.0007
332 VENTRICULAR TACHYCARDIA 12 0.0007
333 VITREOUS HAEMORRHAGE 2 0.0007
334 APPLICATION SITE INFLAMMATION 1 0.0007
335 CHOKING 14 0.0007
336 MALNUTRITION 8 0.0007
337 SKIN INFECTION 8 0.0007
338 INTESTINAL PERFORATION 8 0.0007
339 BUNDLE BRANCH BLOCK LEFT 3 0.0007
340 WHITE BLOOD CELL COUNT DECREASED 76 0.0007
341 ANOREXIA 9 0.0007
342 ATRIAL FIBRILLATION 68 0.0007
343 METASTASES TO CENTRAL NERVOUS SYSTEM 9 0.0007
344 DYSPNOEA AT REST 2 0.0007
345 CYTOMEGALOVIRUS INFECTION REACTIVATION 3 0.0007
346 ABDOMINAL ABSCESS 3 0.0007
347 BLOOD CREATINE INCREASED 3 0.0007
348 RHINITIS ALLERGIC 3 0.0007
349 HISTIOCYTOSIS HAEMATOPHAGIC 2 0.0007
350 PLEURISY 4 0.0007
351 ILEUS PARALYTIC 3 0.0007
352 BRAIN HERNIATION 2 0.0007
353 ATYPICAL PNEUMONIA 2 0.0007
354 BLOOD CULTURE POSITIVE 2 0.0007
355 LEUKOCYTOSIS 12 0.0007
356 RENAL FAILURE ACUTE 28 0.0007
357 DERMATITIS ACNEIFORM 4 0.0007
358 ACUTE GRAFT VERSUS HOST DISEASE 3 0.0007
359 MASTICATION DISORDER 2 0.0007
360 BRAIN NEOPLASM 6 0.0007
361 LIPASE INCREASED 5 0.0007
362 CHRONIC MYELOID LEUKAEMIA 3 0.0006
363 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
364 MENTAL STATUS CHANGES 18 0.0006
365 CHOLANGITIS 4 0.0006
366 BRONCHOPULMONARY ASPERGILLOSIS 5 0.0006
367 MULTIPLE MYELOMA 3 0.0006
368 PLASMA CELL MYELOMA 25 0.0006
369 BLOOD BLISTER 2 0.0006
370 ASPIRATION 7 0.0006
371 INVESTIGATION 2 0.0006
372 PRODUCT USE IN UNAPPROVED INDICATION 157 0.0006
373 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 6 0.0006
374 BLOOD CREATININE INCREASED 41 0.0006
375 NON-SMALL CELL LUNG CANCER 3 0.0006
376 ACUTE LEUKAEMIA 1 0.0006
377 RESPIRATORY ARREST 17 0.0006
378 HERPES SIMPLEX 4 0.0006
379 LYMPHOCYTE COUNT INCREASED 2 0.0006
380 HICCUPS 5 0.0006
381 STAPHYLOCOCCAL SEPSIS 3 0.0006
382 METASTASES TO LUNG 7 0.0006
383 ANTIBODY TEST POSITIVE 1 0.0006
384 FLUID INTAKE REDUCED 3 0.0006
385 PNEUMOCYSTIS JIROVECII PNEUMONIA 6 0.0006
386 BK VIRUS INFECTION 2 0.0006
387 NEOPLASM RECURRENCE 2 0.0006
388 BACTERIAL INFECTION 11 0.0006
389 APPLICATION SITE DRYNESS 2 0.0006
390 SKIN HYPERPIGMENTATION 5 0.0006
391 ACUTE SINUSITIS 1 0.0006
392 EJECTION FRACTION DECREASED 9 0.0006
393 SKIN NECROSIS 3 0.0006
394 PERIORBITAL OEDEMA 3 0.0006
395 ENCEPHALOPATHY 14 0.0006
396 BLOOD LACTIC ACID INCREASED 3 0.0006
397 HAEMOLYTIC ANAEMIA 5 0.0006
398 OESOPHAGITIS 6 0.0005
399 HYPERKERATOSIS 3 0.0005
400 AMYLASE INCREASED 2 0.0005
401 UROSEPSIS 5 0.0005
402 PYREXIA 187 0.0005
403 TRANSAMINASES INCREASED 12 0.0005
404 RASH MACULO-PAPULAR 12 0.0005
405 DYSGEUSIA 40 0.0005
406 CARDIAC DYSFUNCTION 2 0.0005
407 PULMONARY EMBOLISM 50 0.0005
408 LEUKOPENIA 26 0.0005
409 PERICARDIAL EFFUSION 12 0.0005
410 LYMPHOMA 8 0.0005
411 ATELECTASIS 5 0.0005
412 THERAPEUTIC PRODUCT INEFFECTIVE 2 0.0005
413 STAPHYLOCOCCAL INFECTION 17 0.0005
414 FAECES HARD 2 0.0005
415 CARDIOPULMONARY FAILURE 2 0.0005
416 DECREASED APPETITE 119 0.0005
417 NAIL DISCOLOURATION 2 0.0005
418 DEEP VEIN THROMBOSIS 33 0.0005
419 VOMITING 235 0.0005
420 CYTOKINE RELEASE SYNDROME 10 0.0005
421 ENURESIS 2 0.0005
422 FRUSTRATION TOLERANCE DECREASED 4 0.0005
423 PLEURAL EFFUSION 30 0.0005
424 DECUBITUS ULCER 4 0.0005
425 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 5 0.0005
426 ESCHERICHIA INFECTION 4 0.0005
427 HYPERKALAEMIA 17 0.0005
428 SOCIAL PROBLEM 2 0.0005
429 SECOND PRIMARY MALIGNANCY 4 0.0005
430 SYNCOPE 48 0.0005
431 BRAIN OEDEMA 6 0.0005
432 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
433 HAEMATEMESIS 12 0.0005
434 ABSCESS LIMB 2 0.0005
435 ENTERITIS 3 0.0005
436 ACUTE RESPIRATORY FAILURE 9 0.0005
437 BREAST CANCER METASTATIC 5 0.0005
438 HEPATIC LESION 2 0.0005
439 PYELONEPHRITIS 4 0.0005
440 OCULAR ICTERUS 2 0.0005
441 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
442 ASPERGILLUS INFECTION 3 0.0005
443 WOUND INFECTION 5 0.0005
444 GINGIVAL SWELLING 2 0.0005
445 ACUTE RESPIRATORY DISTRESS SYNDROME 8 0.0005
446 GAMMA-GLUTAMYLTRANSFERASE INCREASED 10 0.0005
447 FUNGAL INFECTION 15 0.0004
448 WHEELCHAIR USER 2 0.0004
449 METASTASES TO LYMPH NODES 3 0.0004
450 HAEMATURIA 15 0.0004
451 DISEASE COMPLICATION 2 0.0004
452 SEPTIC SHOCK 19 0.0004
453 SYNOVIAL CYST 2 0.0004
454 LARGE INTESTINE PERFORATION 3 0.0004
455 HYPERTRANSAMINASAEMIA 3 0.0004
456 INFECTION 62 0.0004
457 LEUKAEMIA 4 0.0004
458 LYMPHADENOPATHY 15 0.0004
459 SKIN ABRASION 2 0.0004
460 CYTOMEGALOVIRUS INFECTION 7 0.0004
461 METASTASIS 3 0.0004
462 DIARRHOEA 271 0.0004
463 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0004
464 HYPOVOLAEMIC SHOCK 2 0.0004
465 LOWER LIMB FRACTURE 8 0.0004
466 APHAGIA 2 0.0004
467 HUMERUS FRACTURE 2 0.0004
468 HYPERCHOLESTEROLAEMIA 4 0.0004
469 HEPATITIS C 5 0.0004
470 NOCTURIA 5 0.0004
471 GASTROENTERITIS 6 0.0004
472 THROMBOTIC MICROANGIOPATHY 4 0.0004
473 HYPOTENSION 82 0.0004
474 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0004
475 BREATH SOUNDS ABNORMAL 2 0.0004
476 CEREBRAL DISORDER 3 0.0004
477 HYPERVOLAEMIA 2 0.0004
478 GENERALISED OEDEMA 5 0.0004
479 HYDRONEPHROSIS 3 0.0004
480 GENERAL SYMPTOM 3 0.0004
481 NEUROPATHY PERIPHERAL 38 0.0004
482 PATHOLOGICAL FRACTURE 2 0.0004
483 ENDOCARDITIS 2 0.0004
484 PRODUCT USE ISSUE 73 0.0004
485 PERIPHERAL VASCULAR DISORDER 2 0.0004
486 ATRIOVENTRICULAR BLOCK 3 0.0004
487 INFUSION SITE PAIN 5 0.0004
488 CARDIAC ARREST 32 0.0004
489 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
490 ABDOMINAL PAIN 90 0.0004
491 ACTINIC KERATOSIS 1 0.0004
492 PARTIAL SEIZURES 2 0.0004
493 FOLLICULITIS 4 0.0004
494 STOMATITIS 23 0.0004
495 SERUM FERRITIN INCREASED 2 0.0004
496 LIVER FUNCTION TEST ABNORMAL 11 0.0004
497 TRICUSPID VALVE INCOMPETENCE 3 0.0004
498 ULCER 6 0.0004
499 CELLULITIS 19 0.0004
500 PNEUMONIA 122 0.0004
501 NYSTAGMUS 2 0.0004
502 NEOPLASM PROGRESSION 13 0.0004
503 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
504 FOOD POISONING 2 0.0004
505 COMPRESSION FRACTURE 2 0.0004
506 UPPER RESPIRATORY TRACT INFECTION 17 0.0004
507 SKIN LACERATION 4 0.0004
508 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 3 0.0004
509 INTESTINAL ISCHAEMIA 2 0.0004
510 RESPIRATORY DISTRESS 10 0.0004
511 ACUTE CORONARY SYNDROME 3 0.0004
512 INFUSION RELATED REACTION 24 0.0004
513 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
514 VIRAL INFECTION 12 0.0004
515 NAUSEA 285 0.0004
516 HAEMORRHOIDS 7 0.0004
517 HEART RATE ABNORMAL 2 0.0004
518 BLOOD UREA INCREASED 6 0.0004
519 CONSTIPATION 78 0.0004
520 ORAL PAIN 8 0.0004
521 NEPHROPATHY TOXIC 4 0.0004
522 FEMUR FRACTURE 11 0.0004
523 DISSEMINATED INTRAVASCULAR COAGULATION 5 0.0004
524 CHOLECYSTITIS ACUTE 2 0.0004
525 HYPOPHAGIA 9 0.0004
526 MUSCULAR WEAKNESS 40 0.0004
527 GENERALISED ERYTHEMA 2 0.0004
528 NEUTROPHILIA 2 0.0004
529 HEPATIC FUNCTION ABNORMAL 13 0.0003
530 BLOOD MAGNESIUM DECREASED 3 0.0003
531 BLOOD URIC ACID INCREASED 2 0.0003
532 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 19 0.0003
533 GASTROINTESTINAL DISORDER 31 0.0003
534 URINE OUTPUT DECREASED 3 0.0003
535 HYPOVOLAEMIA 2 0.0003
536 ASCITES 10 0.0003
537 DRUG ERUPTION 6 0.0003
538 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
539 SINUS HEADACHE 2 0.0003
540 PULMONARY HYPERTENSION 7 0.0003
541 CHOLECYSTITIS 4 0.0003
542 CARDIO-RESPIRATORY ARREST 14 0.0003
543 HYPERLIPIDAEMIA 4 0.0003
544 ANAL INCONTINENCE 3 0.0003
545 SQUAMOUS CELL CARCINOMA OF SKIN 2 0.0003
546 PLATELET COUNT ABNORMAL 2 0.0003
547 HERPES ZOSTER 19 0.0003
548 ADRENAL INSUFFICIENCY 4 0.0003
549 NO THERAPEUTIC RESPONSE 4 0.0003
550 LIVER FUNCTION TEST INCREASED 7 0.0003
551 MUSCULOSKELETAL CHEST PAIN 5 0.0003
552 ERYTHEMA MULTIFORME 3 0.0003
553 INFUSION SITE EXTRAVASATION 2 0.0003
554 CLOSTRIDIUM DIFFICILE INFECTION 7 0.0003
555 FLANK PAIN 3 0.0003
556 SQUAMOUS CELL CARCINOMA 3 0.0003
557 BLOOD SODIUM DECREASED 6 0.0003
558 ABDOMINAL DISCOMFORT 53 0.0003
559 CHILLS 37 0.0003
560 GENERAL PHYSICAL HEALTH DETERIORATION 36 0.0003
561 SKIN ULCER 8 0.0003
562 RESPIRATORY TRACT INFECTION 8 0.0003
563 PLATELET COUNT INCREASED 4 0.0003
564 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
565 HEPATOMEGALY 3 0.0003
566 OEDEMA PERIPHERAL 37 0.0003
567 HAEMOGLOBIN DECREASED 31 0.0003
568 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
569 APPETITE DISORDER 2 0.0003
570 CARDIAC FAILURE ACUTE 2 0.0003
571 SALIVARY HYPERSECRETION 3 0.0003
572 SKIN MASS 2 0.0003
573 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
574 CONVULSION 17 0.0003
575 TASTE DISORDER 6 0.0003
576 LYMPHOEDEMA 2 0.0003
577 DIVERTICULITIS 8 0.0003
578 DELIRIUM 10 0.0003
579 AORTIC STENOSIS 1 0.0003
580 ORTHOSTATIC HYPOTENSION 5 0.0003
581 WEIGHT DECREASED 80 0.0003
582 EXTRASYSTOLES 2 0.0003
583 MASS 4 0.0003
584 MULTIPLE ORGAN DYSFUNCTION SYNDROME 8 0.0003
585 FATIGUE 217 0.0003
586 DECREASED ACTIVITY 3 0.0003
587 BONE PAIN 16 0.0003
588 ORAL DISORDER 2 0.0003
589 MOUTH HAEMORRHAGE 2 0.0003
590 ACUTE MYOCARDIAL INFARCTION 8 0.0003
591 LABORATORY TEST ABNORMAL 8 0.0003
592 MEDICAL DEVICE COMPLICATION 2 0.0003
593 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
594 CONJUNCTIVITIS 5 0.0003
595 PULMONARY MASS 4 0.0003
596 HEPATIC STEATOSIS 5 0.0003
597 TREATMENT FAILURE 22 0.0003
598 DYSPNOEA EXERTIONAL 10 0.0003
599 MITRAL VALVE INCOMPETENCE 3 0.0003
600 LOWER RESPIRATORY TRACT INFECTION 12 0.0003
601 URINARY TRACT INFECTION 45 0.0003
602 TROPONIN INCREASED 2 0.0003
603 ACUTE KIDNEY INJURY 40 0.0003
604 EMOTIONAL DISORDER 8 0.0003
605 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 6 0.0003
606 ATAXIA 3 0.0003
607 DISEASE RECURRENCE 12 0.0003
608 PNEUMOTHORAX 4 0.0003
609 ABSCESS 4 0.0003
610 BLOOD DISORDER 2 0.0002
611 ADVERSE EVENT 23 0.0002
612 CONTUSION 24 0.0002
613 THROMBOSIS 20 0.0002
614 FULL BLOOD COUNT DECREASED 5 0.0002
615 APPLICATION SITE DISCOLOURATION 1 0.0002
616 PULMONARY OEDEMA 11 0.0002
617 BODY TEMPERATURE INCREASED 5 0.0002
618 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
619 ANAPHYLACTOID REACTION 1 0.0002
620 APPLICATION SITE EXFOLIATION 1 0.0002
621 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
622 TOOTH EXTRACTION 3 0.0002
623 RENAL FAILURE 32 0.0002
624 OEDEMA 13 0.0002
625 DERMATITIS 5 0.0002
626 FACE OEDEMA 4 0.0002
627 SKIN PLAQUE 2 0.0002
628 URINARY INCONTINENCE 7 0.0002
629 HEMIPARESIS 4 0.0002
630 GASTROOESOPHAGEAL REFLUX DISEASE 19 0.0002
631 CONFUSIONAL STATE 38 0.0002
632 AORTIC VALVE INCOMPETENCE 1 0.0002
633 FACIAL PARALYSIS 2 0.0002
634 THERAPY CESSATION 12 0.0002
635 SEIZURE 27 0.0002
636 BLOOD POTASSIUM DECREASED 7 0.0002
637 ARRHYTHMIA 11 0.0002
638 DYSPNOEA 131 0.0002
639 NODULE 3 0.0002
640 NAIL DISORDER 2 0.0002
641 AMENORRHOEA 4 0.0002
642 BLOOD CALCIUM INCREASED 2 0.0002
643 GASTRITIS 6 0.0002
644 ASTHENIA 85 0.0002
645 PURPURA 2 0.0002
646 EAR INFECTION 6 0.0002
647 RESPIRATORY RATE INCREASED 2 0.0002
648 CARDIAC FAILURE 18 0.0002
649 MYELOSUPPRESSION 8 0.0002
650 PRODUCT TASTE ABNORMAL 3 0.0002
651 OFF LABEL USE 193 0.0002
652 MOOD ALTERED 6 0.0002
653 GINGIVAL BLEEDING 3 0.0002
654 ABDOMINAL HERNIA 1 0.0002
655 PNEUMONIA BACTERIAL 2 0.0002
656 RETINAL DETACHMENT 2 0.0002
657 OVARIAN CANCER 2 0.0002
658 POLLAKIURIA 9 0.0002
659 GASTROINTESTINAL HAEMORRHAGE 18 0.0002
660 HEPATIC ENCEPHALOPATHY 2 0.0002
661 DIARRHOEA HAEMORRHAGIC 2 0.0002
662 FRACTURE 4 0.0002
663 BLOOD URINE PRESENT 4 0.0002
664 INTERNATIONAL NORMALISED RATIO INCREASED 6 0.0002
665 PROTEINURIA 4 0.0002
666 URINARY RETENTION 7 0.0002
667 INCREASED APPETITE 4 0.0002
668 CARDIOGENIC SHOCK 3 0.0002
669 CHOLESTASIS 4 0.0002
670 PRESYNCOPE 5 0.0002
671 NEURALGIA 5 0.0002
672 WEIGHT INCREASED 46 0.0002
673 HEPATIC ENZYME INCREASED 14 0.0002
674 AUTOIMMUNE DISORDER 2 0.0002
675 VITAMIN D DEFICIENCY 2 0.0002
676 RENAL TUBULAR NECROSIS 2 0.0002
677 HOSPICE CARE 2 0.0002
678 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
679 RENAL IMPAIRMENT 17 0.0002
680 IMMUNODEFICIENCY 3 0.0002
681 ANEURYSM 1 0.0002
682 APPLICATION SITE SWELLING 1 0.0002
683 RESPIRATORY DISORDER 6 0.0002
684 DYSPHAGIA 19 0.0002
685 HEPATIC FAILURE 6 0.0002
686 APHASIA 6 0.0002
687 EMPHYSEMA 2 0.0002
688 VAGINAL DISCHARGE 2 0.0002
689 MOTOR DYSFUNCTION 2 0.0002
690 AMMONIA INCREASED 1 0.0002
691 DEATH 168 0.0002
692 DELUSION 3 0.0002
693 DYSPEPSIA 19 0.0002
694 HAEMATOMA 5 0.0002
695 VENTRICULAR EXTRASYSTOLES 2 0.0002
696 BASAL CELL CARCINOMA 3 0.0002
697 INTENTIONAL DRUG MISUSE 4 0.0002
698 DEAFNESS 5 0.0002
699 CYANOSIS 3 0.0002
700 PRODUCT USE COMPLAINT 3 0.0002
701 INCONTINENCE 2 0.0002
702 OBESITY 3 0.0002
703 METABOLIC ACIDOSIS 6 0.0002
704 ANAL FISTULA 1 0.0002
705 INTERSTITIAL LUNG DISEASE 9 0.0002
706 HYPOGLYCAEMIA 9 0.0002
707 COUGH 52 0.0002
708 FAECES DISCOLOURED 4 0.0002
709 HYPERTENSION 39 0.0002
710 MELAENA 4 0.0002
711 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
712 HAEMATOCHEZIA 10 0.0002
713 TACHYCARDIA 16 0.0002
714 COAGULOPATHY 3 0.0002
715 ABDOMINAL PAIN UPPER 37 0.0002
716 FEELING COLD 5 0.0002
717 GAIT INABILITY 6 0.0002
718 ANGIOPATHY 1 0.0002
719 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
720 MYALGIA 30 0.0002
721 DRUG INTOLERANCE 17 0.0002
722 LETHARGY 10 0.0002
723 EYELID OEDEMA 2 0.0002
724 SPLENOMEGALY 2 0.0002
725 PANCREATITIS 9 0.0002
726 BRADYCARDIA 9 0.0002
727 PSYCHOTIC DISORDER 5 0.0002
728 MUSCLE SPASMS 31 0.0002
729 GALLBLADDER DISORDER 3 0.0002
730 ALOPECIA 33 0.0002
731 THIRST 3 0.0002
732 RHABDOMYOLYSIS 7 0.0002
733 BONE DISORDER 3 0.0002
734 HAEMORRHAGE 17 0.0002
735 CARDIOMEGALY 2 0.0002
736 OSTEONECROSIS OF JAW 4 0.0002
737 PHARYNGITIS 2 0.0002
738 AGEUSIA 4 0.0002
739 INJECTION SITE REACTION 11 0.0002
740 HYPOTHYROIDISM 5 0.0002
741 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
742 THERAPY NON-RESPONDER 7 0.0002
743 RASH GENERALISED 4 0.0002
744 EAR PAIN 3 0.0002
745 APPLICATION SITE VESICLES 1 0.0002
746 SWELLING FACE 10 0.0002
747 PRODUCT DOSE OMISSION ISSUE 45 0.0002
748 KIDNEY INFECTION 3 0.0002
749 EYE DISORDER 5 0.0002
750 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
751 SARS-COV-2 TEST POSITIVE 2 0.0002
752 HAEMATOCRIT DECREASED 3 0.0002
753 ADVERSE REACTION 2 0.0002
754 RENAL DISORDER 7 0.0002
755 BLOOD CHOLESTEROL INCREASED 7 0.0002
756 SKIN DISORDER 5 0.0001
757 CARDIAC DISORDER 14 0.0001
758 MALIGNANT MELANOMA 2 0.0001
759 PAIN OF SKIN 4 0.0001
760 DRY MOUTH 12 0.0001
761 ANGER 5 0.0001
762 FALL 49 0.0001
763 PALLOR 4 0.0001
764 PRODUCTIVE COUGH 7 0.0001
765 ILLNESS 15 0.0001
766 ABDOMINAL DISTENSION 15 0.0001
767 INFLUENZA 16 0.0001
768 BLOOD TEST ABNORMAL 2 0.0001
769 SKIN REACTION 2 0.0001
770 PAIN IN JAW 4 0.0001
771 SUBDURAL HAEMATOMA 2 0.0001
772 CEREBRAL HAEMORRHAGE 5 0.0001
773 RECTAL HAEMORRHAGE 6 0.0001
774 ANGINA PECTORIS 4 0.0001
775 POOR QUALITY SLEEP 3 0.0001
776 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
777 PRODUCT PRESCRIBING ISSUE 3 0.0001
778 CRYING 5 0.0001
779 FLUID OVERLOAD 2 0.0001
780 C-REACTIVE PROTEIN INCREASED 5 0.0001
781 PANIC ATTACK 5 0.0001
782 TOXICITY TO VARIOUS AGENTS 23 0.0001
783 HEADACHE 85 0.0001
784 CARDIOMYOPATHY 2 0.0001
785 STEVENS-JOHNSON SYNDROME 3 0.0001
786 GLOSSODYNIA 3 0.0001
787 ECZEMA 7 0.0001
788 SNEEZING 3 0.0001
789 ADVERSE DRUG REACTION 12 0.0001
790 CHROMATURIA 3 0.0001
791 DYSARTHRIA 5 0.0001
792 DIZZINESS 66 0.0001
793 OSTEOPENIA 2 0.0001
794 ANKLE FRACTURE 2 0.0001
795 APHTHOUS ULCER 1 0.0001
796 APNOEA 1 0.0001
797 SINUSITIS 13 0.0001
798 MYOCARDIAL INFARCTION 22 0.0001
799 MOOD SWINGS 4 0.0001
800 OXYGEN SATURATION DECREASED 7 0.0001
801 CARDIAC FAILURE CONGESTIVE 10 0.0001
802 LOCALISED INFECTION 3 0.0001
803 DRUG INEFFECTIVE 163 0.0001
804 CEREBRAL INFARCTION 3 0.0001
805 LUNG DISORDER 6 0.0001
806 METASTASES TO BONE 2 0.0001
807 OSTEOPOROSIS 5 0.0001
808 PHOTOSENSITIVITY REACTION 2 0.0001
809 DRUG LEVEL INCREASED 2 0.0001
810 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
811 PNEUMONIA ASPIRATION 3 0.0001
812 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
813 ABDOMINAL PAIN LOWER 3 0.0001
814 SKIN EXFOLIATION 10 0.0001
815 HEPATITIS 3 0.0001
816 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
817 IRRITABILITY 7 0.0001
818 LOCAL SWELLING 2 0.0001
819 ANHEDONIA 3 0.0001
820 NEUROTOXICITY 2 0.0001
821 COLD SWEAT 2 0.0001
822 CHEST PAIN 21 0.0001
823 RASH 49 0.0001
824 PAIN IN EXTREMITY 33 0.0001
825 GOUT 2 0.0001
826 HEART RATE INCREASED 11 0.0001
827 THROAT TIGHTNESS 3 0.0001
828 INFLUENZA LIKE ILLNESS 9 0.0001
829 RESTLESSNESS 4 0.0001
830 NEPHROLITHIASIS 5 0.0001
831 SKIN DISCOLOURATION 5 0.0001
832 DYSURIA 4 0.0001
833 HAEMOPTYSIS 3 0.0001
834 NECK PAIN 6 0.0001
835 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
836 PHOTOPHOBIA 2 0.0001
837 HALLUCINATION 8 0.0001
838 FOOT FRACTURE 2 0.0001
839 INTENTIONAL DOSE OMISSION 3 0.0001
840 COMA 5 0.0001
841 RED BLOOD CELL COUNT DECREASED 3 0.0001
842 RASH ERYTHEMATOUS 5 0.0001
843 POST PROCEDURAL COMPLICATION 2 0.0001
844 AFFECT LABILITY 1 0.0001
845 PRESCRIBED OVERDOSE 2 0.0001
846 BACK PAIN 24 0.0001
847 MALAISE 45 0.0001
848 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
849 HYPERSENSITIVITY 19 0.0001
850 SKIN FISSURES 2 0.0001
851 UPPER LIMB FRACTURE 2 0.0001
852 CEREBROVASCULAR ACCIDENT 17 0.0001
853 SPINAL FRACTURE 2 0.0001
854 CORONARY ARTERY DISEASE 3 0.0001
855 CHEST DISCOMFORT 10 0.0001
856 DRY SKIN 13 0.0001
857 ERYTHEMA 20 0.0001
858 INFLAMMATION 5 0.0001
859 TOOTH LOSS 2 0.0001
860 NERVOUS SYSTEM DISORDER 3 0.0001
861 CONDITION AGGRAVATED 29 0.0001
862 SOMNOLENCE 19 0.0001
863 CYSTITIS 3 0.0001
864 EATING DISORDER 2 0.0001
865 RETCHING 2 0.0001
866 PRURITUS 36 0.0001
867 PRURITUS GENERALISED 2 0.0001
868 MENTAL DISORDER 4 0.0001
869 INTENTIONAL PRODUCT USE ISSUE 8 0.0001
870 HOSPITALISATION 14 0.0001
871 APPLICATION SITE PAIN 2 0.0001
872 BLOOD PRESSURE DECREASED 6 0.0001
873 NEOPLASM MALIGNANT 6 0.0001
874 HEPATOTOXICITY 2 0.0001
875 PAIN 55 0.0001
876 GAIT DISTURBANCE 17 0.0001
877 FLUSHING 9 0.0001
878 NO ADVERSE EVENT 16 0.0001
879 FLATULENCE 5 0.0001
880 APPLICATION SITE PRURITUS 2 0.0001
881 SHOCK 2 0.0001
882 HYPOAESTHESIA 13 0.0001
883 DYSPHONIA 5 0.0001
884 HYPERHIDROSIS 11 0.0001
885 NASAL CONGESTION 5 0.0001
886 ACCIDENT 1 0.0001
887 DRUG EFFECT INCOMPLETE 3 0.0001
888 ACCIDENTAL OVERDOSE 3 0.0001
889 APPLICATION SITE IRRITATION 1 0.0001
890 COVID-19 14 0.0001
891 ERECTILE DYSFUNCTION 2 0.0001
892 DRUG RESISTANCE 2 0.0001
893 UNRESPONSIVE TO STIMULI 2 0.0001
894 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
895 NERVOUSNESS 4 0.0001
896 APPLICATION SITE ERYTHEMA 2 0.0001
897 NASOPHARYNGITIS 14 0.0001
898 ABNORMAL BEHAVIOUR 3 0.0001
899 OROPHARYNGEAL PAIN 7 0.0001
900 FREQUENT BOWEL MOVEMENTS 2 0.0001
901 VISION BLURRED 10 0.0001
902 APHONIA 1 0.0001
903 WOUND 2 0.0001
904 INSOMNIA 19 0.0001
905 ANXIETY 20 0.0001
906 APATHY 1 0.0001
907 PRODUCT STORAGE ERROR 6 0.0001
908 DYSSTASIA 2 0.0001
909 PALPITATIONS 8 0.0001
910 SURGERY 4 0.0001
911 AGITATION 5 0.0001
912 LIVER DISORDER 3 0.0001
913 DRUG DOSE OMISSION 11 0.0001
914 LACRIMATION INCREASED 2 0.0001
915 THERAPEUTIC RESPONSE DECREASED 4 0.0001
916 DISCOMFORT 4 0.0001
917 BLOOD PRESSURE INCREASED 10 0.0001
918 TINNITUS 3 0.0001
919 PERIPHERAL SWELLING 10 0.0001
920 COGNITIVE DISORDER 3 0.0001
921 BONE DENSITY DECREASED 2 0.0001
922 DRUG-INDUCED LIVER INJURY 2 0.0001
923 PARAESTHESIA 10 0.0001
924 OCULAR HYPERAEMIA 3 0.0001
925 HEAD INJURY 2 0.0001
926 DRUG INTERACTION 10 0.0001
927 LOSS OF CONSCIOUSNESS 8 0.0001
928 OSTEONECROSIS 2 0.0001
929 LIP SWELLING 2 0.0001
930 AGGRESSION 3 0.0001
931 EYE PRURITUS 2 0.0001
932 TYPE 2 DIABETES MELLITUS 2 0.0001
933 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
934 BALANCE DISORDER 5 0.0001
935 INTENTIONAL PRODUCT MISUSE 5 0.0001
936 INJURY 4 0.0001
937 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
938 MOBILITY DECREASED 4 0.0001
939 RASH PRURITIC 3 0.0001
940 UNDERDOSE 4 0.0001
941 BRONCHITIS 4 0.0001
942 SWELLING 5 0.0001
943 MEMORY IMPAIRMENT 7 0.0001
944 ARTHRITIS 4 0.0001
945 WHEEZING 3 0.0001
946 DISORIENTATION 2 0.0001
947 CATARACT 3 0.0001
948 BLOOD GLUCOSE INCREASED 9 0.0000
949 INTENTIONAL OVERDOSE 3 0.0000
950 RHINORRHOEA 3 0.0000
951 VAGINAL HAEMORRHAGE 2 0.0000
952 PRODUCT DOSE OMISSION 3 0.0000
953 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
954 THROAT IRRITATION 2 0.0000
955 SKIN IRRITATION 2 0.0000
956 BURNING SENSATION 3 0.0000
957 TREMOR 7 0.0000
958 THERAPY INTERRUPTED 3 0.0000
959 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
960 ABASIA 1 0.0000
961 HOT FLUSH 3 0.0000
962 UNEVALUABLE EVENT 3 0.0000
963 DEPRESSION 9 0.0000
964 CHRONIC KIDNEY DISEASE 3 0.0000
965 DIABETES MELLITUS 3 0.0000
966 MUSCULOSKELETAL PAIN 2 0.0000
967 SPEECH DISORDER 2 0.0000
968 DEPRESSED MOOD 2 0.0000
969 DISTURBANCE IN ATTENTION 2 0.0000
970 TREATMENT NONCOMPLIANCE 2 0.0000
971 ANAPHYLACTIC REACTION 2 0.0000
972 MEDICATION ERROR 2 0.0000
973 URTICARIA 6 0.0000
974 BLISTER 2 0.0000
975 INCORRECT DOSE ADMINISTERED 8 0.0000
976 MUSCULOSKELETAL STIFFNESS 3 0.0000
977 SUICIDE ATTEMPT 2 0.0000
978 ILL-DEFINED DISORDER 2 0.0000
979 SUICIDAL IDEATION 3 0.0000
980 FEELING HOT 2 0.0000
981 ARTHRALGIA 12 0.0000
982 SLEEP DISORDER 2 0.0000
983 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
984 OVERDOSE 6 0.0000
985 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
986 VISUAL IMPAIRMENT 3 0.0000
987 COMPLETED SUICIDE 2 0.0000
988 BREAST CANCER 2 0.0000
989 MIGRAINE 2 0.0000
990 FEELING ABNORMAL 4 0.0000
991 EMOTIONAL DISTRESS 2 0.0000
992 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
993 INJECTION SITE PAIN 3 0.0000